Jazz Pharmaceuticals Announces U.S. Commercial Availability Of Versaclozâ„¢ (clozapine, USP) Oral Suspension

[at noodls] – First liquid formulation clozapine for treatment-resistant schizophrenia DUBLIN, Feb. 11, 2014 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced U.S. commercial availability of Versaclozâ„¢ … more

View todays social media effects on JAZZ

View the latest stocks trending across Twitter. Click to view dashboard

See who Jazz is hiring next, click here to view